$4.42
-0.025-0.56%
Last update: Nov 12, 9:53 AM
Journey Medical Corp (DERM) Stock Price, Quote, News & History
DERMNASDAQ
Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for...
You can purchase shares of Journey Medical (NASDAQ:DERM) through any online brokerage.
Other companies in Journey Medical’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Journey Medical has a consensus price target of $11.64.
The stock price for Journey Medical (NASDAQ: DERM) is $4.415 last updated November 12, 2026 at 9:53 AM EST.
There are no upcoming dividends for Journey Medical.
Journey Medical does not have any upcoming earnings scheduled.
There is no upcoming split for Journey Medical.
Journey Medical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its...
